title: [Soft-tissue sarcoma: recent developments].
authors.affiliation: Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Campus Großhadern, Marchioninistrasse 15, Munich. lars.lindner@med.uni-muenchen.de
authors.forename: L H
authors.initials: LH
authors.lastname: Lindner
authors.forename: R D
authors.initials: RD
authors.lastname: Issels
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006979:Hyperthermia, Induced / Q000295:instrumentation / Q000379:methods*; D007191:Indazoles; D064847:Multimodal Imaging; D020360:Neoadjuvant Therapy; D049268:Positron-Emission Tomography; D011743:Pyrimidines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012509:Sarcoma / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D013449:Sulfonamides / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; D003841:Deoxycytidine; C515074:ridaforolimus; D003606:Dacarbazine; C516667:pazopanib; D020123:Sirolimus; D000093542:Gemcitabine